Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Pharming Group N.V.-Therapeutic Competitors

Life Science Analytics (LSA)
March 14, 2009
41 Pages - Pub ID: LSA2163481
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication.

Scope of the reports

Life Science Analytics’ Competitor Reports deliver detailed analysis of a company’s preclinical, clinical and marketed pipeline of products.

A complete listing of each company’s entire pipeline is provided along with graphical and tabular presentation of the pipeline by therapeutic or disease category.

Every Competitor Report lists a company’s individual marketed and pipeline products by disease area, as well as detail on public and private company competitors for each.

An overview of each company’s discontinued product line provides insight into product attrition rates.

Life Science Analytics’ Competitor Reports provide extensive information including:


Company business descriptions
Product pipelines by stage of development including discontinued products
Therapeutic areas of research
Indications treated
An extensive list of competitors by disease indication.

Key benefits

Competitor Reports provide the user with independent insight into a company’s management structure, financial position and products - vital intelligence for investors, competitors and partners.

Understand the uniqueness of a company’s pipeline by obtaining detail on competitive products in development by other public and private companies - independent information that will enable the user to make informed strategic decisions.

Graphical representation of data coupled with detailed listings of all products in development and in production allows the user to quickly assess the depth of a company’s pipeline and the strength of the company’s product portfolio.

Related Reports:
Biotechnology (Pharmaceuticals) Report
Publicis Groupe SA - SWOT Analysis
Pirelli & C. S.p.A. - SWOT Analysis
Company Financials: The Pepsi Bottling Group, Inc.
Acorda Therapeutics, Inc. - SWOT Analysis
Peabody Energy Corporation - SWOT Analysis
PPL Corporation - SWOT Analysis
Philippine Long Distance Telephone Company - SWOT Analysis
Philip Morris International Inc. - SWOT Analysis
Performance Food Group - SWOT Analysis

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 2